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Background: Chromophobe renal cell carcinoma is the third most common form of adult renal epithelial
neoplasm. A sarcomatoid component occurs in approximately 8% of all chromophobe renal cell carcinoma cases,
while metaplastic bone formation is extremely rare.
Case presentation: An abdominal computed tomography scan revealed a hypovascular tumor with focal
calcification, measuring 2.5 × 2.3 cm, in the upper pole of the right kidney. The tumor was clinically diagnosed as a
right renal cell carcinoma that showed signs of calcification, and a laparoscopic right radical nephrectomy was
performed. The cut surface of the tumor was beige in color and indicated that the tumor was an extensively ossified
mass. Histological analysis revealed three distinct morphological components of the tumor. The chromophobe
renal cell carcinoma consisted of compact epithelial cells arranged in a nested pattern, and these were mixed
with extensive areas of sarcomatoid spindle cells with marked nuclear pleomorphism and brisk mitotic activity.
The tumor also contained multiple foci of metaplastic ossification.
Conclusion: Chromophobe renal cell carcinoma with concomitant osseous metaplasia and sarcomatoid
transformation is a very rare occurrence.
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Chromophobe renal cell carcinoma (CRCC) is the third
most common form of adult renal epithelial neoplasm,
accounting for 5.9% of all RCC cases [1], and has a
better prognosis than clear cell carcinoma. The 5- and
10-year cancer-specific survival rates have been reported
to be 100% and 90%, respectively [1], although sarcoma-
toid differentiation of CRCC is generally associated with
a worse prognosis [2,3]. Malignant tumors with sarco-
matoid change had a 35% and 27%, 5-year disease-
specific and progression-free survival, respectively [1].
The RCC exhibits various associated secondary changes
that include necrosis, hemorrhage, edema, fibrosis, and
calcification. A sarcomatoid component occurs in ap-
proximately 8% of all CRCC cases [2], while metaplastic
bone formation is extremely rare [4]. Here, we report a* Correspondence: coyama@cc.hirosaki-u.ac.jp
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reproduction in any medium, provided the orunique case of CRCC with concomitant sarcomatoid
transformation and massive osseous metaplasia.
Case presentation
A 77-year-old woman visited our hospital with an inciden-
tally identified right renal tumor by a screening abdominal
ultrasonography procedure for hepatitis C infection. All
laboratory test results were within normal limits. An ab-
dominal computed tomography revealed a hypovascular
tumor with focal calcification, measuring 2.5 × 2.3 cm, in
the upper pole of the right kidney (Figures 1 and 2). The
tumor was clinically diagnosed as a right RCC with calcifi-
cation and was classified as cT1aN0M0, according to the
tumor-node-metastasis system [5]. The patients under-
went the implantation of a pacemaker due to sick sinus
syndrome and had poor ejection fraction. Laparoscopic
right radical nephrectomy was performed. The cut surface
of the tumor was beige in color and indicated that the
tumor was an extensively ossified mass (Figure 3).Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Plain abdominal computed tomography (CT).
Abdominal CT revealed a hypovascular tumor with massive
calcification, measuring 2.5 × 2.3 cm, in the upper pole of the right
kidney (arrow).
Figure 3 Macroscopic findings. Macroscopic examination revealed a
solid, beige colored, and extensively ossified mass, measuring 3 × 2.5 cm,
in the upper pole of the resected kidney (arrow).
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phologic components of the tumor, which consisted of
compact epithelial cells arranged in a nested pattern
(Figure 4). The cells contained eosinophilic cytoplasm
with accentuated cell borders, and the centrally located
nuclei had wrinkled peripheral borders and varying de-
grees of hyperchromatism. Admixed with the CRCC
were extensive areas of sarcomatoid spindle cells with
marked nuclear pleomorphism and brisk mitotic activ-
ity (Figure 5). The spindle cells were arranged in
ill-defined fascicles with a focal storiform pattern, exhi-
biting an aggressive growth pattern with extracapsular
invasion into the adipose tissue. Another feature of this
tumor was the presence of multiple foci of metaplasticFigure 2 Enhanced abdominal computed tomography (CT).
Abdominal CT revealed a hypovascular tumor with massive
calcification, measuring 2.5 × 2.3 cm, in the upper pole of the
right kidney (arrow).ossification (Figure 6). There were also hyaline degen-
erative change and fibrosis in all areas.
The patient is alive and free from disease 12 months
after surgery.
Discussion
To the best of our knowledge, this is the first reported
case of CRCC with concomitant osseous metaplasia and
sarcomatoid transformation.
A number of recent studies concerning the prognosis
of patients with CRCC have reported relatively good sur-
vival rates for this disease [1,6], and cancer-related death
occurred in 22%, 16%, and 8.6% of clear, papillary, and
CRCC cases, respectively [7]. The good survival out-
comes in these cases were probably because more than
70% of patients had organ-confined disease and more
than 60% of tumors were low grade [7].
The incidence of sarcomatoid transformation is
approximately 5% in RCC [8], increasing to 8% in the
CRCC subtype [2,9]. Heterologous sarcomatoid compo-
nents, such as chondrosarcomatous, osteosarcomatous
or rhabdomyosarcomatous component have also been
reported [10]. Akhtar et al. suggested that sarcomatoid
development in CRCC might be associated with its pe-
culiar genetic profile, which makes cells prone to hyper-
ploidization [11]. Bruneli et al. demonstrated that both
Figure 4 Hematoxylin-eosin stained section. (chromophobe renal cell carcinoma. The cells had eosinophilic cytoplasm with accentuated cell
borders and centrally located nuclei that had wrinkled peripheral borders and varying degrees of hyperchromatism (magnification, ×20).
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different genetic abnormalities and that the latter show
multiple gains of chromosomes 1, 2, 6, 10, and 17 [12].
The coexistence of both CRCC and sarcomatoid carcin-
oma may be due to either the dedifferentiation of the
more highly differentiated chromophobe cell tumor or
the coincidental development of two synchronous tumors
[13]. The former model is more widely accepted as it is
based on the evolution of renal carcinoma into a spindle
cell population. This sarcomatoid change may be the re-
sult of extensive chromosomal rearrangement, leading to
identical spindle morphology [12].
Sarcomatoid CRCC is a more aggressive neoplasm
and has a very poor prognosis compared with classicFigure 5 Hematoxylin-eosin stained section. (B: spindle cell component
focal storiform pattern and mitosis (arrow) (magnification, ×200).chromophobe carcinoma [4]. The presence of a sarco-
matoid component has been reported to be associated
with an increased risk of metastasis and an unfavor-
able prognosis [2,9,14]. Previously reported cases of
CRCC with sarcomatoid differentiation have shown
distant organ metastases to sites including the bone,
liver, lung, and lymph nodes [14].
RCCs exhibit a number of changes such as hemorrhage,
necrosis, fibrosis, and hyalinization. However, although
calcification is a well-recognized feature of renal tumors,
they are rarely ossified. Daniel reported that 10.3% of
RCCs had calcified foci, based on a review of 2,709 renal
masses at the Mayo Clinic [15]. Moreover, reports of his-
topathologically confirmed osseous metaplasia or bone). The spindle cells were arranged in ill-defined fascicles that had a
Figure 6 Hematoxylin-eosin stained section. (osseous metaplasia). Metaplastic ossification was apparent (magnification, ×20).
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fication in CRCC, however, was noted in four previously
reported cases [4].
The mechanism of ossification is unclear, although
it might involve a metaplastic or reparative response
either in the tumor or in the surrounding tissue, the
production of bone by tumor cells, or the ossification
of a preexisting mucin or calcium deposit [4]. Osse-
ous metaplasia may occur secondary to ischemia, ne-
crosis, or inflammation in the tumor or surrounding
tissues [4].
The prognostic significance of ossification in CRCC re-
mains unclear because of the limited number of cases re-
ported to date. However, several studies demonstrated that
ossification is a significant prognostic marker for patients
with RCC [4,17] and is usually representative of an early
stage without invasion or metastasis [17]. Therefore, RCC
with osseous metaplasia implies a more favorable progno-
sis, although this is contradicted by some reports, suggest-
ing that ossification is actually associated with high-grade
tumors and a poor prognosis [18].
Conclusion
In conclusion, CRCC with concomitant osseous meta-
plasia and sarcomatoid transformation is a very rare oc-
currence. It is important to recognize that this unusual
variant of renal cancer has the potential to behave ag-
gressively and to metastasize.
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